Literature DB >> 24034667

Effect of allopurinol on blood pressure (author response to Allopurinol on hypertension: insufficient evidence to recommend).

Vikram Agarwal1, Franz Messerli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24034667      PMCID： PMC8033834          DOI： 10.1111/jch.12152

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  5 in total

1.  Allopurinol: novel indications in cardiovascular disease.

Authors:  Allan Struthers; Fiona Shearer
Journal:  Heart       Date:  2012-07-16       Impact factor: 5.994

2.  Thiazide diuretics and the initiation of anti-gout therapy.

Authors:  J H Gurwitz; S C Kalish; R L Bohn; R J Glynn; M Monane; H Mogun; J Avorn
Journal:  J Clin Epidemiol       Date:  1997-08       Impact factor: 6.437

3.  Acute adverse reactions attributed to allopurinol in hospitalised patients.

Authors:  G T McInnes; D H Lawson; H Jick
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

4.  Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program.

Authors:  H G Langford; M D Blaufox; N O Borhani; J D Curb; A Molteni; K A Schneider; S Pressel
Journal:  Arch Intern Med       Date:  1987-04

Review 5.  Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

Authors:  Vikram Agarwal; Nidhi Hans; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-20       Impact factor: 3.738
  5 in total
  2 in total

1.  Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.

Authors:  Kenichi Tanaka; Masaaki Nakayama; Makoto Kanno; Hiroshi Kimura; Kimio Watanabe; Yoshihiro Tani; Yoshimitsu Hayashi; Koichi Asahi; Hiroyuki Terawaki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2015-02-13       Impact factor: 2.801

2.  Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP.

Authors:  Todd A Johnson; H A Jinnah; Naoyuki Kamatani
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.